Serum Tau Species in Progressive Supranuclear Palsy: A Pilot Study
Diagnostics · 05.12.2024 · 14 (23) · 2746
DOI: 10.3390/diagnostics14232746 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 05.12.2024. Verfasst von Costanza Maria Cristiani und 5 weiteren Autor:innen. Beteiligte Einrichtung: Neuroscience Research Center, Department of Medical and Surgical Sciences, University "Magna Graecia", 88100 Catanzaro, Italy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of University and Research (MUR), National Recovery and Resilience Plan (NRRP), NEXTGENERATIONEU (NGEU), Italian Ministry of University and Research (MUR), National Recovery and Resilience Plan (NRRP), project MNESYS (PE0000006).
Abstract (Originalsprache)
Background/Objectives: Progressive Supranuclear Palsy (PSP) is a tauopathy showing a marked symptoms overlap with Parkinson’s Disease (PD). PSP pathology suggests that tau protein might represent a valuable biomarker to distinguish between the two diseases. Here, we investigated the presence and diagnostic value of six different tau species (total tau, 4R-tau isoform, tau aggregates, p-tau202, p-tau231 and p-tau396) in serum from 13 PSP and 13 PD patients and 12 healthy controls (HCs).
Methods
ELISA commercial kits were employed to assess all the tau species except for t-tau, which was assessed by a single molecule array (SIMOA)-based commercial kit. Possible correlations between tau species and biological and clinical features of our cohorts were also evaluated.
Results
Among the six tau species tested, only p-tau396 was detectable in serum. Concentration of p-tau396 was significantly higher in both PSP and PD groups compared to HC, but PSP and PD patients showed largely overlapping values. Moreover, serum concentration of p-tau396 strongly correlated with disease severity in PSP and not in PD.
Conclusions
Overall, we identified serum p-tau396 as the most expressed phosphorylated tau species in serum and as a potential tool for assessing PSP clinical staging. Moreover, we demonstrated that other p-tau species may be present at too low concentrations in serum to be detected by ELISA, suggesting that future work should focus on other biological matrices.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Neuroscience Research Center, Department of Medical and Surgical Sciences, University "Magna Graecia", 88100 Catanzaro, Italy.
- Institute of Molecular Biology, Department of Medical and Surgical Sciences, University "Magna Graecia", 88100 Catanzaro, Italy.
- Research Centre for Advanced Biochemistry and Molecular Biology, Department of Clinical and Experimental Medicine, University "Magna Graecia", 88100 Catanzaro, Italy.
- Institute of Neurology, Department of Medical and Surgical Sciences, University "Magna Graecia", 88100 Catanzaro, Italy.
ORCID-Profile: Costanza Maria Cristiani, Luana Scaramuzzino, Elvira Immacolata Parrotta, Giovanni Cuda
Förderung
- Italian Ministry of University and Research (MUR), National Recovery and Resilience Plan (NRRP)
- NEXTGENERATIONEU (NGEU)
- Italian Ministry of University and Research (MUR), National Recovery and Resilience Plan (NRRP), project MNESYS (PE0000006)
Zitieren
APA
Cristiani, C. M., Scaramuzzino, L., Parrotta, E. I., Cuda, G., Quattrone, A., & Quattrone, A. (2024). Serum Tau Species in Progressive Supranuclear Palsy: A Pilot Study. Diagnostics, 14(23), 2746. https://doi.org/10.3390/diagnostics14232746
Vancouver
Cristiani CM, Scaramuzzino L, Parrotta EI, Cuda G, Quattrone A, Quattrone A. Serum Tau Species in Progressive Supranuclear Palsy: A Pilot Study. Diagnostics. 2024;14(23):2746. doi:10.3390/diagnostics14232746
BibTeX
@article{Cristiani2024,
author = {Cristiani, Costanza Maria and Scaramuzzino, Luana and Parrotta, Elvira Immacolata and Cuda, Giovanni and Quattrone, Aldo and Quattrone, Andrea},
title = {Serum Tau Species in Progressive Supranuclear Palsy: A Pilot Study},
journal = {Diagnostics},
year = {2024},
volume = {14},
number = {23},
pages = {2746},
doi = {10.3390/diagnostics14232746}
}
EUVIMED